Effects of interleukin 2 therapy in patients with common variable immunodeficiency (CVID).
作者信息
Rump J A, Jahreis A, Schlesier M, Stecher S, Dräger R, Struff W G, Peter H H
机构信息
Dept. of Rheumatology, University of Freiburg, FRG.
出版信息
Immunodeficiency. 1993;4(1-4):37-42.
PMID:8167730
Abstract
摘要
相似文献
1
Effects of interleukin 2 therapy in patients with common variable immunodeficiency (CVID).
Immunodeficiency. 1993;4(1-4):37-42.
2
On interleukins 4, 6 and 10 and their interrelationship with immunoglobulins G and M in common variable immunodeficiency.关于白细胞介素4、6和10及其在常见可变免疫缺陷中与免疫球蛋白G和M的相互关系。
Cell Biol Int. 1994 Nov;18(11):1067-75. doi: 10.1006/cbir.1994.1030.
3
Grouping of patients with common variable immunodeficiency based on immunoglobulin biosynthesis: comparison with a classification system on CD4-naïve cells.基于免疫球蛋白生物合成对常见可变免疫缺陷患者进行分组：与CD4初始细胞分类系统的比较。
Immunol Lett. 2007 Dec 15;114(2):103-9. doi: 10.1016/j.imlet.2007.09.006. Epub 2007 Oct 11.
4
Anti-CD28 enhances defective mitogen responses by mononuclear cells from patients with common variable immunodeficiency.
Immunodeficiency. 1993;4(1-4):17-8.
5
6
Brief report: enhanced humoral immunity in common variable immunodeficiency after long-term treatment with polyethylene glycol-conjugated interleukin-2.简短报告：聚乙二醇缀合白细胞介素-2长期治疗后常见变异型免疫缺陷患者体液免疫增强
N Engl J Med. 1994 Oct 6;331(14):918-21. doi: 10.1056/NEJM199410063311405.
7
Amelioration of differentiation of dendritic cells from CVID patients by intravenous immunoglobulin.静脉注射免疫球蛋白改善常见变异型免疫缺陷病患者树突状细胞的分化
Am J Med. 2005 Dec;118(12):1439-40. doi: 10.1016/j.amjmed.2005.06.028.
8
A comparison of the effects of cyclosporine and steroids on human T lymphocyte responses.环孢素和类固醇对人T淋巴细胞反应影响的比较。
Transplant Proc. 1988 Apr;20(2 Suppl 2):233-9.
9
Common variable immunodeficiency: familial inheritance and autoimmune manifestations in two siblings.普通可变免疫缺陷：两例同胞的家族遗传及自身免疫表现
Turk J Pediatr. 2010 Jan-Feb;52(1):89-93.
10
Pharmacokinetics of a new 10% intravenous immunoglobulin in patients receiving replacement therapy for primary immunodeficiency.一种新型10%静脉注射免疫球蛋白在接受原发性免疫缺陷替代治疗患者中的药代动力学。
Eur J Pharm Sci. 2009 Jun 28;37(3-4):272-8. doi: 10.1016/j.ejps.2009.02.014. Epub 2009 Mar 6.
引用本文的文献
1
Leukocytoclastic vasculitis and long-term remission in a patient with secondary AML and post-remission treatment with low-dose interleukin-2.一名继发性急性髓系白血病患者的白细胞破碎性血管炎与长期缓解及低剂量白细胞介素-2缓解后治疗
Ann Hematol. 1995 Apr;70(4):227-30. doi: 10.1007/BF01700380.
Zotero 插件